Latest Intelligence

Published within

« | ... | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | ... | » »|

Type Product title / description Pub Price
NewsWire
NewsWire

United Airlines November passenger traffic decreases

United Airlines, Inc. has reported that consolidated passenger traffic for the month of November 2014 was 15.28 billion revenue passenger miles, a decrease of 0.3%, compared to 15.33 billion revenue passenger miles for November 2013.

Published By MarketLine
18 Dec 2014
NewsWire
NewsWire

Rex Industry Q3 profit increases

Rex Industry Bhd, a manufacturer of canned food, frozen food and drinks, has reported that profit attributable to owners of the company for the third quarter ended September 30, 2014 was MYR568,000, or 1.01 sen per basic share, compared to MYR301,000, or 0.54 sen per basic share, for the same quarter ended September 30, 2013.

Published By MarketLine
18 Dec 2014
NewsWire
NewsWire

OncoGenex completes patient enrollment in Phase II pancreatic cancer trial

OncoGenex Pharmaceuticals, Inc., a biopharmaceutical company, has completed the patient enrollment in the Rainier clinical trial, an investigator-sponsored, randomized, placebo-controlled Phase II trial evaluating apatorsen in combination with ABRAXANE and gemcitabine in patients with previously untreated metastatic pancreatic cancer.

Published By MarketLine
18 Dec 2014
NewsWire
NewsWire

Associated Bank appoints senior vice president and relationship manager

Associated Bank, N.A., a provider of deposit and loan products, has appointed Erik Zimmerman as senior vice president and relationship manager.

Published By MarketLine
18 Dec 2014
NewsWire
NewsWire

AGTech Holdings Q3 loss increases

AGTech Holdings Limited, an integrated gaming company, has reported that loss attributable to owners of the company for the third quarter ended September 30, 2014 was HK$48.95 million, or a loss of 1.112 cents per share, compared to a loss attributable to owners of the company of HK$21.47 million, or a loss of 0.501 cents per share, for the same quarter ended September 30, 2013.

Published By MarketLine
18 Dec 2014
NewsWire
NewsWire

DURECT and Santen sign license agreement for ophthalmology drug

DURECT Corporation, a specialty pharmaceutical company, has entered into an agreement with Santen Pharmaceutical Co., Ltd. granting Santen the exclusive worldwide rights to develop and commercialize a sustained release product utilizing DURECT's SABER technology to deliver an ophthalmology drug.

Published By MarketLine
18 Dec 2014
NewsWire
NewsWire

United Therapeutics announces management changes

United Therapeutics Corporation, a biotechnology company, has announced the promotion of Roger Jeffs as president and co-CEO and David Zaccardelli as executive vice president and COO.

Published By MarketLine
18 Dec 2014
NewsWire
NewsWire

HALMA H1 profit increases

HALMA plc has reported that profit attributable to equity shareholders for the first six months ended September 27, 2014 was GBP47.54 million, or 12.56 pence per diluted share, compared to GBP42.62 million, or 11.27 pence per diluted share, for the same period ended September 28, 2013.

Published By MarketLine
18 Dec 2014
NewsWire
NewsWire

Ipsen receives FDA approval for treatment of GEP-NETs

Ipsen SA, a specialty pharmaceutical company, has received FDA approval for Somatuline Depot, or lanreotide, Injection 120mg for the treatment of adult patients with unresectable, well- or moderately-differentiated, locally advanced or metastatic gastroenteropancreatic neuroendocrine tumors, or GEP-NETs.

Published By MarketLine
18 Dec 2014
NewsWire
NewsWire

Tata Steel Q2 net profit increases

Tata Steel Limited has reported that net profit after taxes, minority interest and share of profit of associates for the second quarter ended September 30, 2014 was INR12.54 billion, or INR12.46 per share, compared to INR9.17 billion, or INR8.98 per share, for the same quarter ended September 30, 2013.

Published By MarketLine
18 Dec 2014

« | ... | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | ... | » »|

No help is available.